These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 30853557)

  • 1. MAP4K4 Inhibition Promotes Survival of Human Stem Cell-Derived Cardiomyocytes and Reduces Infarct Size In Vivo.
    Fiedler LR; Chapman K; Xie M; Maifoshie E; Jenkins M; Golforoush PA; Bellahcene M; Noseda M; Faust D; Jarvis A; Newton G; Paiva MA; Harada M; Stuckey DJ; Song W; Habib J; Narasimhan P; Aqil R; Sanmugalingam D; Yan R; Pavanello L; Sano M; Wang SC; Sampson RD; Kanayaganam S; Taffet GE; Michael LH; Entman ML; Tan TH; Harding SE; Low CMR; Tralau-Stewart C; Perrior T; Schneider MD
    Cell Stem Cell; 2019 Apr; 24(4):579-591.e12. PubMed ID: 30853557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical trial of a MAP4K4 inhibitor to reduce infarct size in the pig: does cardioprotection in human stem cell-derived myocytes predict success in large mammals?
    Te Lintel Hekkert M; Newton G; Chapman K; Aqil R; Downham R; Yan R; Merkus D; Whitlock G; Lane CAL; Cawkill D; Perrior T; Duncker DJ; Schneider MD
    Basic Res Cardiol; 2021 May; 116(1):34. PubMed ID: 34018053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective protection of human cardiomyocytes from anthracycline cardiotoxicity by small molecule inhibitors of MAP4K4.
    Golforoush PA; Narasimhan P; Chaves-Guerrero PP; Lawrence E; Newton G; Yan R; Harding SE; Perrior T; Chapman KL; Schneider MD
    Sci Rep; 2020 Jul; 10(1):12060. PubMed ID: 32694738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of MG53 Enhances Cell Survival and Engraftment of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in Injured Hearts.
    Park KH; He X; Jiang L; Zhu H; Liang J; Wang Y; Ma J
    Stem Cell Rev Rep; 2023 Oct; 19(7):2420-2428. PubMed ID: 37477774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of mitophagy in human iPSC-derived cardiomyocytes.
    Yang M; Fu JD; Zou J; Sridharan D; Zhao MT; Singh H; Krigman J; Khan M; Xin G; Sun N
    Autophagy; 2022 Oct; 18(10):2481-2494. PubMed ID: 35220905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Examining the protective role of ErbB2 modulation in human-induced pluripotent stem cell-derived cardiomyocytes.
    Eldridge S; Guo L; Mussio J; Furniss M; Hamre J; Davis M
    Toxicol Sci; 2014 Oct; 141(2):547-59. PubMed ID: 25055963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-cadherin overexpression enhances the reparative potency of human-induced pluripotent stem cell-derived cardiac myocytes in infarcted mouse hearts.
    Lou X; Zhao M; Fan C; Fast VG; Valarmathi MT; Zhu W; Zhang J
    Cardiovasc Res; 2020 Mar; 116(3):671-685. PubMed ID: 31350544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MAP4K4 expression in cardiomyocytes: multiple isoforms, multiple phosphorylations and interactions with striatins.
    Fuller SJ; Edmunds NS; McGuffin LJ; Hardyman MA; Cull JJ; Alharbi HO; Meijles DN; Sugden PH; Clerk A
    Biochem J; 2021 Jun; 478(11):2121-2143. PubMed ID: 34032269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of Novel Small-Molecule Inducers of Heme Oxygenase-1 That Protect Human iPSC-Derived Cardiomyocytes from Oxidative Stress.
    Kirby RJ; Divlianska DB; Whig K; Bryan N; Morfa CJ; Koo A; Nguyen KH; Maloney P; Peddibhotla S; Sessions EH; Hershberger PM; Smith LH; Malany S
    J Pharmacol Exp Ther; 2018 Jan; 364(1):87-96. PubMed ID: 29101218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutralizing MAP4K4.
    Nicholls M
    Eur Heart J; 2019 Jun; 40(22):1752-1753. PubMed ID: 31173092
    [No Abstract]   [Full Text] [Related]  

  • 11. Combined Treatment of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes and Endothelial Cells Regenerate the Infarcted Heart in Mice and Non-Human Primates.
    Cheng YC; Hsieh ML; Lin CJ; Chang CMC; Huang CY; Puntney R; Wu Moy A; Ting CY; Herr Chan DZ; Nicholson MW; Lin PJ; Chen HC; Kim GC; Zhang J; Coonen J; Basu P; Simmons HA; Liu YW; Hacker TA; Kamp TJ; Hsieh PCH
    Circulation; 2023 Oct; 148(18):1395-1409. PubMed ID: 37732466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting HIF-1α in combination with PPARα activation and postnatal factors promotes the metabolic maturation of human induced pluripotent stem cell-derived cardiomyocytes.
    Gentillon C; Li D; Duan M; Yu WM; Preininger MK; Jha R; Rampoldi A; Saraf A; Gibson GC; Qu CK; Brown LA; Xu C
    J Mol Cell Cardiol; 2019 Jul; 132():120-135. PubMed ID: 31082397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tri-iodo-l-thyronine promotes the maturation of human cardiomyocytes-derived from induced pluripotent stem cells.
    Yang X; Rodriguez M; Pabon L; Fischer KA; Reinecke H; Regnier M; Sniadecki NJ; Ruohola-Baker H; Murry CE
    J Mol Cell Cardiol; 2014 Jul; 72():296-304. PubMed ID: 24735830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnesium lithospermate B enhances the potential of human-induced pluripotent stem cell-derived cardiomyocytes for myocardial repair.
    Fan C; Qin K; Iroegbu CD; Xiang K; Gong Y; Guan Q; Wang W; Peng J; Guo J; Wu X; Yang J
    Chin Med J (Engl); 2024 Aug; 137(15):1857-1869. PubMed ID: 38221772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Changes in Morphology and Function of Human Induced Pluripotent Stem Cell Derived Cardiomyocytes (HiPSC-CMs) Cultured on an Aligned-Nanofiber Cardiac Patch.
    Khan M; Xu Y; Hua S; Johnson J; Belevych A; Janssen PM; Gyorke S; Guan J; Angelos MG
    PLoS One; 2015; 10(5):e0126338. PubMed ID: 25993466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Danshen-Enhanced Cardioprotective Effect of Cardioplegia on Ischemia Reperfusion Injury in a Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes Model.
    Wei W; Liu Y; Zhang Q; Wang Y; Zhang X; Zhang H
    Artif Organs; 2017 May; 41(5):452-460. PubMed ID: 27925238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MMI-0100 Inhibits Cardiac Fibrosis in a Mouse Model Overexpressing Cardiac Myosin Binding Protein C.
    Meng Q; Bhandary B; Osinska H; James J; Xu N; Shay-Winkler K; Gulick J; Willis MS; Lander C; Robbins J
    J Am Heart Assoc; 2017 Sep; 6(9):. PubMed ID: 28871043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of In Vitro Drug-Induced Cardiotoxicity Assay by Using Three-Dimensional Cardiac Tissues Derived from Human Induced Pluripotent Stem Cells.
    Takeda M; Miyagawa S; Fukushima S; Saito A; Ito E; Harada A; Matsuura R; Iseoka H; Sougawa N; Mochizuki-Oda N; Matsusaki M; Akashi M; Sawa Y
    Tissue Eng Part C Methods; 2018 Jan; 24(1):56-67. PubMed ID: 28967302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silencing of Long Non-coding RNA GAS5 Suppresses Neuron Cell Apoptosis and Nerve Injury in Ischemic Stroke Through Inhibiting DNMT3B-Dependent MAP4K4 Methylation.
    Deng Y; Chen D; Gao F; Lv H; Zhang G; Sun X; Liu L; Mo D; Ma N; Song L; Huo X; Yan T; Zhang J; Luo Y; Miao Z
    Transl Stroke Res; 2020 Oct; 11(5):950-966. PubMed ID: 31997156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In Vivo Maturation of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in Neonatal and Adult Rat Hearts.
    Kadota S; Pabon L; Reinecke H; Murry CE
    Stem Cell Reports; 2017 Feb; 8(2):278-289. PubMed ID: 28065644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.